STAT3 Inhibitor for Solid Tumors

Clinical trial NCT00955812 · COMPLETED

Trial details

NCT number: NCT00955812
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Solid Tumor

Start date: 2009-06-01
Primary completion: 2012-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.